Bo Liang

Clinical and Antiviral Efficacy of an Ophthalmic Formulation of Dexamethasone Povidone-Iodine in a Rabbit Model of Adenoviral Keratoconjunctivitis

Christian Clément, Joseph Capriotti, Manish Kumar et al. · Investigative Ophthalmology & Visual Science · 2010 · 79 citations · Full text

Pharmacy, Ophthalmology, Veterinary Ophthalmology +14

A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis

Jesse Pelletier, Kevin Stewart, William Trattler et al. · Advances in Therapy · 2009 · 70 citations

Pharmacy, Infectious Diseases, Ophthalmology +11

In vitro efficacy of a povidone–iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens

Jesse Pelletier, Darlene Miller, Bo Liang et al. · Journal of Cataract & Refractive Surgery · 2011 · 32 citations

Life Sciences, Microbiology, Ophthalmology +17

<i>In-Vivo</i> Toxicity Studies and <i>In-Vitro</i> Inactivation of SARS-CoV-2 by Povidone-iodine <i>In-situ</i> Gel Forming Formulations

Bo Liang, Xudong Yuan, Gang Wei et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 24 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutics +17

Fine Particulate Matter (PM2.5) and the Blood–Testis Barrier: An <i>in Vivo</i> and <i>in Vitro</i> Mechanistic Study

Shaokai Zheng, Nannan Zhao, Xiaojun Lin et al. · Environmental Health Perspectives · 2025 · 11 citations · Full text

Pharmacy, Molecular Biology, Toxicology +17